Recent biochemical characterization of tau in GGT shows distinct templating properties of 4R tau (with RT-QuIC assays [72]) in GGT compared to PSP and other 4R tauopathies. The gene discussed is MAPT; the disease is supranuclear palsy, progressive, 1.